Kidney Research and Clinical Practice
Practical guidance on the use of sacubitril/valsartan for heart failure | SpringerLink
PDF) Estimating the Lifetime Benefits of Treatments for Heart Failure
JCM | Free Full-Text | Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan | Circulation: Cardiovascular Quality and Outcomes
IJMS | Free Full-Text | Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure
Frontiers | Assessment of Ultra-Early Administration of Sacubitril Valsartan to Improve Cardiac Remodeling in Patients With Acute Myocardial Infarction Following Primary PCI: Rational and Design of a Prospective, Multicenter, Randomized Controlled Trial
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review - Rui Zhang, Xiaotong Sun, Ya Li, Wenzheng He, Hongguang Zhu, Baoshan Liu, Aiyuan Zhang, 2022
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Sacubitril/Valsartan For Heart Failure & Ejection Fraction
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF - ScienceDirect
Sacubitril/Valsartan: Neprilysin Inhibition 5 Years After PARADIGM-HF | JACC: Heart Failure
A randomized clinical trial on the short‐term effects of 12‐week sacubitril/ valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY‐HF study -
IJERPH | Free Full-Text | ARNI in HFrEF—One-Centre Experience in the Era before the 2021 ESC HF Recommendations
Frontiers | Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial | JACC: Heart Failure
JCM | Free Full-Text | Antiarrhythmic Effect of Sacubitril-Valsartan: Cause or Consequence of Clinical Improvement?
Forest plot of indirect comparisons used to estimate the effects of... | Download Scientific Diagram
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction | JACC: Heart Failure
Estimating the Long-Term Treatment Benefits of Sacubitril–Valsartan | NEJM
Sacubitril/valsartan in Heart Failure and Beyond—From Molecular Mechanisms to Clinical Relevance
Sacubitril/Valsartan: Where are we now? | BCS
Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - ScienceDirect
Clinical outcomes of Sacubitril/Valsartan in patients with acute heart failure: A multi-institution study - eClinicalMedicine
Frontiers | Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
